Disclosed herein are compositions that comprise at least one methyl alpha-glucan ether derivative. Examples include methyl alpha-1,3-glucan ethers, and methyl alpha-glucan graft copolymer ethers such as methyl dextran-alpha-1,3-glucan graft copolymer ethers. Further disclosed are methods of producing methyl ether derivatives, as well as their use in various applications and products.
Disclosed herein are compositions that comprise at least one methyl alpha-glucan ether derivative. Examples include methyl alpha-1,3-glucan ethers, and methyl alpha-glucan graft copolymer ethers such as methyl dextran-alpha-1,3-glucan graft copolymer ethers. Further disclosed are methods of producing methyl ether derivatives, as well as their use in various applications and products.
Disclosed herein are malodor control compositions comprising a bacterial fermentate extract, or fraction thereof, and a functionalized polysaccharide and methods of use thereof. More particularly, the present disclosure relates to compositions containing bacterial fermentate extracts, or fractions thereof, together with functional polysaccharides and optionally enzymes that are suitable for use as detergents and for preventing, reducing, or removing a malodor of fabrics and hard surfaces, as well as in a variety of other applications.
Disclosed herein are cleaning compositions comprising a bacterial fermentate extract and a functionalized polysaccharide, and methods if use thereof. More specifically, the present disclosure relates to compositions containing bacterial fermentate extracts, or fractions thereof, together with functional polysaccharides and optionally enzymes that are suitable for use as detergents and for cleaning of fabrics and hard surfaces, as well as in a variety of other applications.
The invention described herein include the conversion of alginate that do not have the required mechanical and chemical properties for their use as alginate raft-forming oral suspension (AROS) for Gastroesophageal reflux disease (GERD) therapy into compliant alginate polysaccharides for AROS. The invention consists of the reaction of an epimerase enzyme with alginate polysaccharides containing a high amount of β-D-mannuronic acid sugars in their backbone to obtain alginate polysaccharide with high α-L-guluronic acid content. The reaction of the AlgE6R enzyme converts mannuronic sugars into guluronic sugars by creating long sequence of guluronic sugars increasing the blockiness of the resulting alginate. The invention combines the enzymatic treatment with a hydrolysis step to obtain alginate solutions that not only forms strong hydrogel but exhibit low viscosity in raft formulation offering the possibility to provide a better swallowability for GERD patients.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Emulsifiers for industrial purposes; Emulsifiers for use in the manufacture of foods; Chemical thickeners for use in the manufacture of pharmaceuticals, food, cosmetics, household products; Chemicals, namely, rheology modifiers for use in the field of coating materials
Disclosed herein are various products/compositions, such as food products and other ingestible products, that comprise beta-1,3-glucan. The beta-1,3-glucan can have a degree of polymerization (DP) of 8 to 27 or 8 to 16, and at least about 90% of the glycosidic linkages of the beta-1,3-glucan are beta-1,3 glycosidic linkages, for example. The beta-1,3-glucan typically is dispersed and/or otherwise undissolved in non-aqueous conditions or low-aqueous conditions within the product. Methods are further disclosed for preparing and using these products.
Disclosed herein are various products/compositions, such as personal care products and pharmaceutical products, that comprise beta-1,3-glucan. The beta-1,3-glucan can have a degree of polymerization (DP) of 8 to 27 or 8 to 16, and at least about 90% of the glycosidic linkages of the beta-1,3-glucan are beta-1,3 glycosidic linkages, for example. The beta-1,3-glucan typically is dispersed and/or otherwise undissolved in non-aqueous conditions or low-aqueous conditions within the product. Methods are further disclosed for preparing and using these products.
The present disclosure relates, in part, to addition of glucosyl- or glucano-transferase type enzymes for producing and/or modifying alpha-glucan type structures in dough such as bread dough. Such enzymes encompass, for example, (i) dextrin dextranases, (ii) glucosyltransferases, and (iii) glucosyl-, maltosyl-, maltotetrasyl-, or glucano-transferases, where these enzymes can transfer glucose to/from starch and starch hydrolysate substrates (e.g., dextrin, amylodextrin, and/or maltodextrin) for production and/or modification of alpha-glucan type polymers in bread dough. Further disclosed are methods of preparing a baked food product by baking a farinaceous dough, comprising incorporating into the dough one or more of the foregoing enzymes – e.g., a glucosyl- or glucano-transferase type enzyme – wherein the enzyme can transfer a glucose-based moiety from a polysaccharide or oligosaccharide substrate to the non-reducing end of an oligosaccharide acceptor, thereby improving bread volume and/or dough stability. Further disclosed are modified alpha-glucans for use as food ingredients in general.
C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
11.
METHODS AND COMPOSITIONS FOR AGING AND MITOCHONDRIAL HEALTH
Provided herein are compositions for enabling natural adaptive spacer acquisition in CRISPR-Cas systems incapable of adaptation, e.g., non-adapting lactococcal CRISPR-Cas systems. Also provided are methods for using the compositions and products thereof to produce bacterial strains that are resistant, such as bacteriophage resistant, and/or evolved to have a desirable phenotype. Non-adapting CRISPR-Cas systems adapted according to the methods provided herein, and bacteria containing such adapted non-adapting CRISPR-Cas systems, are further provided. The compositions and methods provided herein allow for the controlled induction of natural spacer acquisition via adaptation in CRISPR-Cas systems that are fundamentally incapable of adaptation without modifying the features underlying the non-adapting behavior of the CRISPR-Cas system.
The present invention relates to a method or treating plant proteins with enzymes to produce a plant-based food, including plant-based meat alternatives. More particularly, the method relates to use of transglutaminase, a sugar oxidase, and catalase to treat plant-based proteins.
Provided herein, inter alia, are compositions and methods for treating and/or preventing conditions associated with gut inflammation caused by dysbiosis via use of exogenously administered acid phosphatases or enzymes of the GDA1_CD39 superfamily (such as apyrases).
A phospholipase A1 characterized by having an sn1/sn2 specificity ratio of about 55/45 or greater wherein said phospholipase A1 has a lysophospholipase/phospholipase activity ratio of less than 0.01 is presented in conjunction with methods for use in lipid containing food matrix, baking and making dough with the phospholipase and also including baking improvers using the disclosed phospholipase A1.
inter aliainter alia, are compositions comprising one or more biologically pure strains of bacteria as well as methods of making and using the same to treat and/or prevent one or more obesity related disorders in a subject in need thereof.
This specification relates to a process for preparing a purified human milk oligosaccharide ("HMO") from an HMO-containing solution (e.g., a fermentation broth) by a process comprising mixed bed ion exchange, and a product of such a process.
C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A23C 9/146 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
20.
PROCESS FOR PURIFYING A HUMAN MILK OLIGOSACCHARIDE AND RELATED COMPOSITIONS
This specification relates to a process for preparing a purified human milk oligosaccharide ("HMO") from an HMO-containing solution (e.g., a fermentation broth) by a process comprising anion ion exchange, cation ion exchange, and mixed bed ion exchange; and a product of such a process.
C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
A23C 9/146 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
21.
PROCESS FOR REDUCING OXIDATION OF A FOODSTUFF AND RELATED COMPOSITIONS
This specification relates to a process for reducing oxidation of a foodstuff, an antioxidant composition for use in such a process, and a foodstuff wherein oxidation is reduced by such a process.
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
23.
COMPOSITION AND USE THEREOF IN AN EMULSION OR A FOODSTUFF
The present disclosure relates to a composition that exhibits an antioxidant action. The present disclosure also relates to an emulsion or a foodstuff comprising the composition and to the use of the composition for preventing and/or inhibiting oxidation of an emulsion or a foodstuff. Moreover, the present disclosure relates to a process for preventing and/or inhibiting oxidation of an emulsion or a foodstuff comprising contacting a foodstuff or an emulsion with the composition. The present disclosure also relates to a composition that can impart flavour, and to the use of the composition for imparting flavour to an emulsion or a foodstuff.
This specification relates to preparing a purified human milk oligosaccharide (HMO) from an HMO solution by a process comprising nanofiltration, as well as processes for making foods, dietary supplements, medicines and infant formulas comprising a purified HMO. This specification also relates to purified HMOs and foods, dietary supplements, medicines and infant formulas prepared by processes disclosed in this specification.
A23C 9/12 - Fermented milk preparationsTreatment using microorganisms or enzymes
A23C 9/142 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
A23C 9/20 - Dietetic milk products not covered by groups
This specification relates to a process for preparing fucose from a human milk oligosaccharide ("HMO") comprising a fucose moiety, as well as L-fucose compositions prepared by such a process.
C07H 1/08 - SeparationPurification from natural products
C12P 1/04 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymesGeneral processes for the preparation of compounds or compositions by using microorganisms or enzymes by using bacteria
The present invention relates to methods of mashing 100% adjunct grists. More specifically, the instant disclosure provides methods and compositions wherein an alpha-amylase in combination with an maltogenic alpha amylase and/or glucoamylse to make a non-malt wort composed by adjunct raw materials.
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
C12C 12/00 - Processes specially adapted for making special kinds of beer
A system for treating a food product with a mold inhibitor via spray application in suspended form includes a conveyor for moving the food product as well as at least one upper spray nozzle above the conveyor and at least one lower spray nozzle located below the conveyor. In an embodiment of the invention, one or more end spray nozzles are provided to spray one or more vertical end surfaces of the food product. A fluid supply system for supplies pressurized fluid to the spray nozzles. In an embodiment of the invention, the fluid supply system includes a recirculating reservoir for maintaining the mold inhibitor in suspension. The spray guns are controlled via pulse width modulation such that the instantaneous flow rate and the time averaged flow rate are equal to respective predetermined allowable flow rates.
A23C 19/11 - Addition of preservatives of antibiotics
B05B 15/08 - Means for adjusting position of spray heads
B05B 1/04 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops in flat form, e.g. fan-like, sheet-like
A21D 15/08 - Improving finished bakery products by coating
A system for treating a food product with a mold inhibitor via spray application in suspended form includes a conveyor for moving the food product as well as at least one upper spray nozzle above the conveyor and at least one lower spray nozzle located below the conveyor. In an embodiment of the invention, one or more end spray nozzles are provided to spray one or more vertical end surfaces of the food product. A fluid supply system for supplies pressurized fluid to the spray nozzles. In an embodiment of the invention, the fluid supply system includes a recirculating reservoir for maintaining the mold inhibitor in suspension. The spray guns are controlled via pulse width modulation such that the instantaneous flow rate and the time averaged flow rate are equal to respective predetermined allowable flow rates.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
29 - Meat, dairy products, prepared or preserved foods
30 - Basic staples, tea, coffee, baked goods and confectionery
32 - Beers; non-alcoholic beverages
Goods & Services
Reduced calorie bulking agents, fat-replacers and chemical
sweeteners, all for use in the manufacture of food,
beverages and animal feed. Chemical sweeteners for medical use. Dairy products, jams, marmalade and stewed fruit; desserts
made on the basis of dairy products. Natural sweeteners, bread, meat and vegetable pies, tarts,
biscuits, cakes, shortcrust pastry, pastries and
confectionery, puddings, edible ices, muesli products
including snack products made primarily from muesli,
beverages made on the basis of coffee, cocoa or chocolate. Non-alcoholic beverages.
01 - Chemical and biological materials for industrial, scientific and agricultural use
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
Antimicrobial preparations for inhibiting microbiological decomposition in food, beverage, animal feed and pharmaceuticals; mould inhibitors for use in the production of cheese and sausages. Natural preservatives for use in foodstuffs, including salts.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
Low-calorie bulking agents, fat replacers and chemical sweeteners, all for use in the manufacture of food, beverages and animal feed. Chemical sweeteners for medical purposes. Natural sweeteners.
